Repeated courses of certain antibiotics associated with increased diabetes risk
the ONA take:
Repeated use of penicillins, cephalosporins, quinolones, and macrolides may increase people's risk of developing type 2 diabetes by changing their gut flora, a recent study published in the European Journal of Endocrinology has shown.
Researchers from the Departments of Gastroenterology and Medical Oncology at the University of Pennsylvania in Philadelphia, Pennsylvania, analyzed data from over 200,000 diabetics in the UK prescribed antibiotics in the years before diagnosis and compared the number of antibiotic prescriptions to the number prescribed to 800,000 non-diabetics.
Results showed that patients who were prescribed at least two courses of penicillins, cephalosporins, quinolones, and macrolides were at an increased risk of being diagnosed with type 2 diabetes.
Researchers also found that the risk increased with repeated antibiotic courses. The researchers suggest that the association between antibiotic use and diabetes may be due to antibiotics altering the diversity of gut bacteria.
Researchers found no that suggests anti-virals or anti-fungals increase the risk of type 2 diabetes and minimal evidence to support a link between antibiotics and an increased risk of type 1 diabetes.
The findings emphasize the necessity to decrease the number of unnecessary antibiotic prescriptions.
Repeated use of antibiotics may increase people's risk of developing type 2 diabetes by changing their gut flora.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|